E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/16/2012 in the Prospect News Bank Loan Daily.

Bausch & Lomb to launch $3.485 billion credit facility on Thursday

By Sara Rosenberg

New York, April 16 - Bausch & Lomb is scheduled to hold a bank meeting at 10 a.m. ET on Thursday in New York to launch a proposed $3.485 billion credit facility, according to a market source.

Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. and Bank of America Merrill Lynch are the bookrunners on the deal.

The facility consists of a $500 million revolver, a $2.035 billion covenant-light term loan B, a $600 million covenant-light euro term loan B and a $350 million covenant-light delayed-draw term loan, the source said.

Proceeds will be used to refinance existing debt and fund the acquisition of ISTA Pharmaceuticals Inc. for $9.10 per share in cash, or a total of about $500 million.

Closing on the acquisition is expected in the second quarter, subject to regulatory approval and other customary conditions, including the approval of ISTA's shareholders.

Bausch & Lomb is a Rochester, N.Y.-based eye health company. ISTA is an Irvine, Calif.-based branded prescription eye care business.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.